Yrjö Tapio Konttinen 1952–2014

نویسندگان

  • Jukka Pajarinen
  • Dan Nordström
  • Tom Petterson
  • Mari Ainola
  • Enrique Gómez-Barrena
  • Michiaki Takagi
  • Stuart B. Goodman
چکیده

Open Access-This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the source is credited. died unexpectedly on the 10th of December 2014 at the age of 62. Professor Konttinen will be remembered as an exceptionally productive and highly cited scientist in the fields of musculoskeletal and rheumatic diseases, as well as an inspirational mentor and teacher to a generation of medical doctors and scientists. Yrjö T. Konttinen was born on September 28th 1952 in Helsinki. He received his M.D. degree from the University of Helsinki and the University of Uppsala in 1977, and was board certified in internal medicine and rheumatology from the University of Helsinki. He began his scientific career early, during medical school, and defended his Ph.D. thesis dealing with the immunology of rheumatic diseases in 1981. His supervisor and mentor at the time was Professor Otto Wegelius. Professor Konttinen served as research director, and later as a scientific advisor, of the Invalid Foundation's Orthopae-dic Hospital, Orton; as a scientific advisor for Coxa Hospital for Joint Replacement; from 2001 to 2003 as President of the Finnish Society for Rheumatology; and from 2007 as Vice-director of the National Doctoral Program of Musculoskeletal Disorders and Biomaterials. Yrjö T. Konttinen was an enthusiastic and creative scientist who never grew tired of " reading stories from the golden book of nature " , wording that he often used to describe the process of scientific discovery. Together with his dear friend and colleague, the late Seppo Santavirta, Professor of Ortho

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Mast Cells and Synovial Fibroblasts as Novel Targets for Antirheumatic Therapy

Cover: Synovial fi broblasts isolated from tissue of a patient with rheumatoid arthritis and immunohistochemically stained with antibodies for Th y-1.

متن کامل

Prevention of deep infection in joint replacement surgery

1Coxa, Hospital for Joint Replacement, Tampere; 2Geriatric Unit, Seinäjoki Central Hospital, Seinäjoki, Finland; 3Department of Orthopedic Surgery, Haukeland University Hospital, Bergen; 4Department of Surgical Sciences, University of Bergen, Norway; 5Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland; 6Department of Orthopedics, Aarhus University Hospital, Aarhus, ...

متن کامل

Inflammatory Mediators in Autoimmunity and Systemic Autoimmune Diseases

1Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, Oslo, Norway 2Department of Genetics, Cell and Immunobiology, Semmelweis University, Budapest, Hungary 3K. G. Jebsen Center for Influenza Vaccine Research, Institute of Immunology, University of Oslo and Oslo University Hospital, Oslo, Norway 4Department of Medicine, Institute of Clinical Medicine, Helsin...

متن کامل

Mesenchymal stem cells and cardiac repair

Accumulating clinical and experimental evidence indicates that mesenchymal stem cells (MSCs) are promising cell types in the treatment of cardiac dysfunction. They may trigger production of reparative growth factors, replace damaged cells and create an environment that favours endogenous cardiac repair. However, identifying mechanisms which regulate the role of MSCs in cardiac repair is still a...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 86  شماره 

صفحات  -

تاریخ انتشار 2015